Authors


Martine C. Maculaitis, PhD

Latest:

Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice

Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.


Joseph R. Betancourt, MD, MPH

Latest:

Addressing Virtual Care Disparities for Patients With Limited English Proficiency

With increased use of virtual care due to the COVID-19 pandemic, the following recommendations address disparities for patients with limited English proficiency.


Enrico Repetto, MD

Latest:

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose monitoring.


Margaret I. Liang, MD, MS

Latest:

Cost Sharing for Oral Lenvatinib Among Commercially Insured Patients

Among a cohort of insured patients with cancer, the median total monthly cost of oral lenvatinib was $17,253, and 75% of patients paid $100 or less out of pocket per month for the drug.


Parul Mistry, MD, MA

Latest:

Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care Population

A Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.


Lindsay Dymowski

Latest:

Contributor: How Pharmacists and Providers Can Improve Patient Care

Pharmacists and pharmacies can be doing more to help with medication management for their patients.



Jonathan T. Rawlins, MA

Latest:

Improving Pain Clinic Outcomes With Preappointment Surveys: Data-Driven Policy Change

Implementing a policy change to require preappointment surveys before scheduling initial clinic evaluations can improve wait-list times and show rates.


Deborah R. Kaye, MD, MS

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Andrew D. Schreiner, MD, MSCR

Latest:

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

In this study, authors assessed the proportion of patients with nonalcoholic fatty liver disease (NAFLD) receiving prescriptions for statins in primary care.


James Motyka, PharmD

Latest:

Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications

The Inflation Reduction Act will likely change incentives surrounding single-indication launches and postapproval research for additional indications in small molecule drugs, affecting patient access.


Sunny C. Lin, PhD, MS

Latest:

Bundled Payments Lead to Quality Improvements in Hospitals’ Skilled Nursing Facility Referral Networks

The Bundled Payments for Care Improvement program was associated with improved quality of skilled nursing facilities in hospital referral networks for patients undergoing surgery for joint replacement.


Arshad Rahim, MD, MBA

Latest:

Stakeholder Insights on rtCGM in T2D Population Health Management

Leading payer and health system stakeholders reviewed literature and shared insights on the value of real-time continuous glucose monitoring (rtCGM) in type 2 diabetes (T2D) population health.


John Allan, MD

Latest:

Final Thoughts on Bispecifics in B-Cell Lymphomas From ASH 2024

Panelists share their final thoughts on bispecific therapies in B-cell lymphomas based on insights from the 66th American Society of Hematology (ASH) Annual Meeting and Exposition 2024.



Micaela Mercado, PhD, LMSW

Latest:

Implementation of the Accountable Health Communities Model in Arizona

The Accountable Health Communities Model facilitates multisector coordination. Implementation science elucidated the contextual factors that facilitated the use of this model in Arizona.


Soo Borson, MD

Latest:

Utilization of Low- and High-Value Health Care by Individuals With and Without Cognitive Impairment

Low-value service utilization is common among all older adults, and utilization of some high-value services decreases after the onset of cognitive decline.


Richard Freeman, MD

Latest:

Successes and Failures With Bundled Payments in the Commercial Market

The relatively few examples of commercially funded condition-specific bundled payments provide insights into how to spread this alternative payment model further in the private insurance market.


Karen O. Moss, PhD, RN, CNL

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Kathryn Brignole, MSc

Latest:

Pervasiveness and Clinical Staff Perceptions of HPV Vaccination Feedback

This article used regression analyses to quantify how clinical staff perceive provider feedback to improve human papillomavirus (HPV) vaccination rates and determine the prevalence of such feedback.


Anuraag R. Kansal, PhD

Latest:

Cost-Effectiveness of a Multicancer Early Detection Test in the US

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.


Shishir Maharjan, MS

Latest:

Continuity of Opioid Prescribing Among Older Adults on Long-term Opioids

Among older adults with chronic noncancer pain on long-term opioid therapy, greater continuity of opioid prescribing was significantly associated with fewer opioid-related adverse outcomes.


Dr Andrew S. Oseran | Image Credit: Beth Israel Deaconess Medical Center
Andrew S. Oseran, MD, MBA, MSc

Latest:

Further Research Into Medicare Advantage Upcoding, Documentation Accuracy Needed

Andrew S. Oseran, MD, MBA, MSc, hypothesizes that higher Medicare Advantage (MA) risk scores may result from either a more accurate capture of beneficiaries' comorbidities or inappropriate "upcoding" of conditions.


Nynikka R. Palmer, DrPH, MPH

Latest:

“Can You Hear Me Now?”: Postoperative Patient-Initiated Communication With Providers

Patient-provider communication after surgery is critical for patient safety. The growth of patient-provider communication technologies has created opportunities to study postoperative patient-initiated communication.


Selen Bozkurt, PhD

Latest:

Characterizing Patient Flow After an Academic Hospital Merger and Acquisition

This study assessed health care utilization and patient flow after a recent merger of community practices, a community hospital, and an academic medical center.


Fatima Cody Stanford, MD, MPH, MPA, MBA

Latest:

Financial Crossroads of Care: Physicians’ Struggle and Patient Outcomes

In 2024, physicians face significant financial challenges due to declining Medicare reimbursement rates and high student loan interest rates, which will impact health care delivery and access.



Dennis Hwang, MD

Latest:

Cost-effectiveness of a 3-Year Tele-Messaging Intervention for Positive Airway Pressure Use

Long-term tele-messaging was more effective than no messaging and short-term messaging for positive airway pressure use, and it was highly likely to be cost-effective with an acceptable willingness-to-pay threshold.


Patricia Wonch Hill, PhD

Latest:

Influence of Prior Authorization Requirements on Provider Clinical Decision-Making

An online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.


David M. Anderson, MSPPM

Latest:

Changes in Marketplace Competition and Television Advertising by Insurers

This study provides the first evidence on how Marketplace insurers are altering their marketing in response to changes in competitive pressure over time.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo